Nanosonics (NAN:ASX) Annual Reports & Investor Relations Material

Overview

Nuveen Investments, Inc has launched a closed-ended fixed income mutual fund known as the Nuveen New York Quality Municipal Income Fund. The fund, co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC, invests in New York's fixed income markets through municipal bonds rated 'Baa' or higher. Employing fundamental analysis and a bottom-up stock picking approach to build its portfolio, the fund compares its performance against Standard & Poor's New York Municipal Bond Index and Standard & Poor's National Municipal Bond Index. The fund was previously known as Nuveen New York Dividend Advantage Municipal Fund and was established on May 26, 1999, with domicile in the United States.

Frequently Asked Questions

What is Nanosonics's ticker?

Nanosonics's ticker is NAN

What exchange is Nanosonics traded on?

The company's shares trade on the ASX stock exchange

Where are Nanosonics's headquarters?

They are based in New South Wales, Australia

How many employees does Nanosonics have?

There are 51-200 employees working at Nanosonics

What is Nanosonics's website?

It is nanosonics.com/about-us/our-story

What type of sector is Nanosonics?

Nanosonics is in the Healthcare sector

What type of industry is Nanosonics?

Nanosonics is in the Medical Appliances & Equipment industry

Who are Nanosonics's peers and competitors?

The following five companies are Nanosonics's industry peers:

- Advanced Oncotherapy

- Edwards Lifesciences

- RA Medical Systems

- Rockwell Medical

- Cochlear